Icatibant Injection
Product Images NDC 69097-664

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 69097-664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 01

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 02

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 03

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 04

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 05

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 06

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 07

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 08

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 09

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 10

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 11

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 12

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 13

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 14

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 15

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 16

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 17

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 18

Icatibant Injection is a prescription medicine that is available in a prefilled syringe for subcutaneous use only. It contains 30 mg/3 mL of Icatibant and is manufactured by Cipla Ltd. in India for Cipla USA, Inc. It is a prescription-only medicine and should be used as directed by a healthcare professional. All necessary manufacturer information is included on the packaging.*

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 19

Icatibant Injection is a subcutaneous injection medication developed by Cipla Ltd., India and manufactured for Clpla USA, Inc., Warren, NJ 07059. Each 3 mL Prefilled Syringe contains 30 mg/3 mL (10mg/mL) of Icatibant Injection. The product is designed for subcutaneous use only. No additional useful information is available due to the limited nature of the text provided.*

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 20

Icatibant injection is a medicine available in a concentration of 30 mg/3 mL used for treatment purposes.*

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 21

This is a description of the Icatibant Injection, which is a medication used for subcutaneous use only. It comes in a pre-filled syringe with a strength of 30 mg/3 mL (10 mg/mL). The product has a National Drug Code of 69007-664-68. The provided text also includes other irrelevant characters and symbols.*

FDA Label Image

38971837 750d 4016 Bc05 618d00dacf0d 22

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.